ChiCTR2100043429
结束
/
/
/
2021-02-17
/
/
diabetes
Which score to predict diabetes remission?
Predicting diabetes remission after bariatric surgery: Which score should we use?
To validate the performance of available risk prediction scores for diabetes remission 1 year after surgical treatment and determine optimal model.
连续入组
回顾性研究
As the design of the study is retrospective and comprises only one group, the randomization procedure was not required.
N/A
The study required no funding
/
252
/
2019-10-22
2020-06-10
/
We included consecutive patients with T2DM who underwent bariatric surgery, eighter laparoscopic sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) in our hospital and completed 1 year of postoperative follow-up.；
请登录查看Patients with already existing severe complications of T2DM, type 1 diabetes mellitus as well as history of bariatric surgery and those who were qualified for reoperation were excluded from the study.；
请登录查看The study required no funding
/
The study required no funding的其他临床试验
波兰2nd Department of General Surgery, Jagiellonian University Medical College, Kraków, Poland.的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29